Are AbbVie and J&J already fighting to acquire Galapagos’ pipeline?
Ten years ago, Galapagos completed its initial public offering with a dual listing in Amsterdam…
Ten years ago, Galapagos completed its initial public offering with a dual listing in Amsterdam…
Indivior obtained top-line results from its phase III clinical trial of RBP-7000, a candidate treatment…
GlaxoSmithKline has become the first big pharma company to file a gene therapy approval case to the…
MorphoSys has acquired the Dutch biopharmaceutical company Lanthio Pharma. Morphosys already held 19.98% of Lanthio…
What happens when your liver stops working? The toxins your body continuously produces will no longer…
Omeicos Therapeutics has appointed Dr. Ulrich Dauer as Chief Executive Officer. The company, that recently…
Gilead Sciences has acquired the small Danish biotech EpiTherapeutics for €57M. The epigenetics-expert has generated…
Currently, the pharma industry is going through a serious crisis, as the sector needs to review…
Global Bioenergies delivered the first batch of isobutene from renewable resources to its partner Arkema…
AstraZeneca, Bayer and Nestlé have entered Flagship Ventures’ ranks. The three big-shots will share their know…
British Kymab raised an additional €44.4M to its already very successful Series B financing. The…
Hello Tomorrow's main goal is to create bridges between scientists, investors and entrepreneurs in all…